Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C. Méndez Méndez"'
Autor:
Nieves Martínez-Lago, Ana Fernández-Montes, Marta Covela, Elena M. Brozos, Juan De la Cámara, José C. Méndez Méndez, Mónica Jorge-Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo, David Arias Ron, María L. Pellón Augusto, Paula González Villarroel, Begoña Graña, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López, On behalf of the Galician Research Group on Digestive Tumors (GITuD)
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of
Externí odkaz:
https://doaj.org/article/0205a0ed5fdf486f96be2430c7159205
Autor:
Nieves Martinez Lago, Ana Fernández Montes, Marta Covela Rúa, Elena M. Brozos Vázquez, Juan C. De la Cámara Gómez, Jose C. Méndez Méndez, Mónica Jorge Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo Rendo, David Arias Ron, Marta Carmona Campos, Yolanda Vidal Insua, Maria L. Pellón Augusto, Paula González Villarroel, Begoña Graña Suarez, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López
Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of antiangi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4516fdfd7ed86ceeb492a6f2d08d1f56
https://doi.org/10.21203/rs.3.rs-79440/v1
https://doi.org/10.21203/rs.3.rs-79440/v1
Autor:
C. Fernández Martos, Carles Pericay, Miriam Cuatrecasas, Esther Casado, Antonieta Salud, Jorge Aparicio, Xabier García-Albéniz, A. Carmona, C. Méndez Méndez, H. Manzano, Jesús Gallego, Jaime Feliu, M. Martín Richard, Carlos Horndler, Juan Maurel, Vicente Alonso, Michele Rubini
Publikováno v:
Annals of Oncology. 27:vi164
Autor:
Jorge Aparicio, Miriam Cuatrecasas, C. Méndez Méndez, Juan Maurel, Xabier García-Albéniz, Michele Rubini, M. Martin-Richard, Carles Pericay, Ruth Vera
Publikováno v:
Journal of Clinical Oncology. 29:TPS164-TPS164
TPS164 Background: By transactivaction, p-IGF-IR can activate epidermal growth factor receptor (EGFR). Matrilysin (MMP-7), can activate IGF-IR by degrading IGFBP-3 and releasing IGF-I. Concomitant expression of MMP-7 and p-IGF-IR (using a specific mo
Autor:
M. Ramos Vazquez, M. Salgado Fernandez, M. Jorge Fernandez, C. Romero Reinoso, C. Méndez Méndez, M. Reboredo López, J. De la Cámara Gómez, Guillermo Quintero-Aldana, S. Candamio Folgar, R. Rebolo Lopez
Publikováno v:
Journal of Clinical Oncology. 29:277-277
277 Background: Patients with metastatic pancreatic cancer (mPC) have poor prognosis. Given the activity of both capecitabine and erlotinib in pancreatic cancer, we hypothesized that combination use of two drugs in first-line therapy would improve cl